Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Role of Anti-Inflammatory Agents in Patients With Schizophrenia

NCT00929955 is registered in ClinicalTrials.gov with Pakistan Institute of Living and Learning as lead sponsor.

NCT NCT00929955
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00929955 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Role of Anti-Inflammatory Agents in Patients With Schizophrenia
Lead sponsor
Pakistan Institute of Living and Learning
Phase
Phase 1
Overall status
Completed
Start date
June 30, 2009
Completion date
September 30, 2010
Enrollment
36 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

psychosis not otherwise specified, schizoaffective disorder, schizophrenia, schizophreniform disorder